Geldanamycin (GA), a benzoquinone ansamycin, is a naturally occurring inhibitor of heat shock protein (Hsp90), which regulates the transcription activity of hypoxia-inducible factor 1 (HIF-1a). Under hypoxia, HIF-1a is activated in tumor cells, and induces the transcription of vascular endothelial growth factor (VEGF), which is the prime regulator for angiogenesis. VEGF promotes the formation of new blood vessels by stimulating endothelial cell division and migration. This eventually forms a vascular network that allows for tumor growth and metastasis. In this study, we used GA to inhibit HIF-1a transcription function. Human prostate cancer DU-145 cells were incubated in a hypoxic chamber at 1% O 2 and 371C for different durations. Both mRNA and protein levels of HIF-1a and VEGF were upregulated under hypoxic conditions. We demonstrated that GA treatment of hypoxic DU-145 cells abolished the induction of HIF-1a protein in a time-dependent manner and decreased VEGF mRNA and its protein levels. The transient transfection of DU-145 cells with luciferase reporter gene construct (5HRE/hCMVmp-luc) showed that the transcriptional activity of HIF-1a was significantly induced in response to hypoxia, but inhibited by GA. In addition, using conditioned medium from GA-treated hypoxic cells led to a significant decrease in cell invasion in comparison with using conditioned medium from nontreated hypoxic cells. These data provide evidence for the important role of GA in inhibition of angiogenesis and also invasion mediated by HIF-1a in prostate cancer cells.
Introduction
Hypoxia-inducible factor 1 (HIF-1a) is a transcription factor that activates different genes involved in cancer cell growth and invasion. The overexpression of HIF-1a protein has been demonstrated in many common human cancers including prostate and breast cancer, in which HIF-1a levels were associated with increased vascularity and tumor progression. 1, 2 During the hypoxia, HIF-1a is forming a hetrodimer with HIF-1b and that mediates the transcription activity of target genes encode angiogenic factors, glucose transporters and glycolic enzymes, survival and invasion factors. HIF-1 is comprised of a subunit that is targeted for degradation by ubiquitin ligase, von Hippel-Lindau tumour-suppressor protein (pVHL) in normoxic conditions, while HIF-1b, or aryl hydrocarbon nuclear translocator (ARNT), is constitutively expressed. 3 Under hypoxic conditions, prolyl hydroxylation of HIF-1a is inhibited and thereby preventing VHL from targeting HIF-1a for degradation. Thus, an increase in HIF-1a production leads to an enhancing of the HIF transcription activity by HIF-1a/ HIF-1b heterodimers. 4 This hetrodimer is a basic-helixloop-helix (bHLH)-PAS transcription factor that activates genes encoding erythropoietin, transferrin, endothelin-1, inducible nitric oxide synthase, heme oxygenase1, vascular endothelial growth factor (VEGF), insulin-like growth factor-2 (IGF-2), insulin-like growth factor binding protein-1, -2 and -3 (IGFBP-1, -2 and -3), glucose transporters, and glycolytic enzymes. 5, 6 Interestingly, most of these proteins are associated with tumor progression. Various studies have demonstrated that HIF-1a regulates the hypoxic induction of multidrug resistance transporter P-glycoprotein (P-gp) that causes resistance of some tumors to chemotherapeutics. 7 HIF-2a, a structurally related protein forms a hetrodimer with HIF-1b and binds to hypoxic response elements (HRE). HIF-2a has been shown to regulate a number of the same hypoxia-inducible genes as HIF-1a in certain cell types. 8, 9 Other genes regulated by hypoxia include VEGF, also known as vascular permeability factor (VPF). 10 VEGF protein consists of five major isoforms (VEGF 121 , VEGF 145 , VEGF 165 , VEGF 189 , and VEGF 206 ) that are produced by alternative splicing of the gene, which VEGF 165 is the most common isoform. 11 VEGF plays a critical role in angiogenesis because of its effect on endothelial cell growth. 12 The biological function of VEGF is mediated by two tyrosine kinase receptors, Flt1 (VEGFR1), and KDR (VEGF2). 13 VEGF promotes the formation of new blood vessels by stimulating endothelial cell division and migration. 14, 15 During angiogenesis, endothelial cells initially respond to changes in local environment and migrate toward the growing tumor. They then migrate together forming tubular structures that are eventually encapsulated by recruiting periendothelial support cells to form a vascular network that allows for tumor growth and metastasis. In Leukemic cells, it has been shown that MMP-9 production is dependent on VEGF stimulation and that VEGF deprivation caused a decrease in collagenase production. 16 VEGF induces MMP-1, MMP-3 and MMP-9, which have been linked to prostate cancer metastasis. Human prostate cancer cells grown in nude mice have shown that tumors treated with a KDR neutralizing antibody caused a decrease in MMP-9 production by endothelial cells. However, the neutralizing antibody did not affect alternative sources of MMP-9. Hypoxic pathways other than VEGF may also regulate matrix metalloproteinases (MMP). 17 Reduced oxygen levels stimulate MMP-9 expression in a highly invasive, metastatic breast cancer cell line, but did not have an effect on MMP-2 expression. They, however, did not see the same induction of MMP-9 in a poorly metastatic breast cancer cell line. 18 MMP-2 and MMP-9 expression were not changed under hypoxic conditions for a wide range of cell lines tested including prostate cancer cell lines. 19 These differences may be related to the malignant potential of various cell lines.
HIF-1a interacts with the molecular chaperone heat shock protein90 (Hsp90) that mediates the proper folding and subsequent activation of its numerous client proteins. Hsp90 also cooperates with the proteasomal pathway to eliminate misfolded cellular proteins. 20, 21 The antibiotic GA associates with Hsp90 and modulates its chaperone function by accelerating the degradative activity associated with Hsp90. 22, 23 The ability of GA to promote the proteasome-dependent degradation of client proteins including HIF-1a provides it as a potential antitumor agent. However, the effect of GA on prostate tumor cells under hypoxic conditions is not well defined. In this study, we examined the inhibition of HIF-1a by GA and its effect on angiogenesis and the invasion of prostate cancer cells, DU-145. We demonstrated that the treatment of hypoxic DU-145 cells with GA resulted in a reduction of HIF-1a expression, and VEGF mRNA levels. This led to a decrease in cell invasion of the hypoxic cells compared to nontreated DU-145 cells. Given that, GA is a promising drug to inhibit HIF-1a mediated tumor angiogenesis and metastasis in hypoxic prostate cancer cells.
Materials and methods

Materials
The cell lines used, namely DU-145, PC-3, and LNCaP were obtained from ATCC. CL-1 cell line is derived from LNCaP (gift from Dr Belledegrun, UCLA). RPMI 1640 medium and fetal bovine serum (FBS) were purchased from Invitrogen (Carlsbad, CA). GA and CoCl 2 were purchased from Sigma Chemical Co. (St Louis, MO). HIF-1a monoclonal antibody was purchased from Novus Biologicals (Littleton, CO).
Cell culture
DU-145, PC-3, and LNCaP Cells were cultured in RPMI 1640 medium, supplemented with 10% fetal bovine serum, 100 mM HEPES solution, and 1% penicillin/ streptomycin. For normoxic conditions cells were incubated in a humidified atmosphere of 5% CO 2 at 371C. For hypoxic conditions cells were placed in a chamber with oxygen controller (BioSpherix) providing 1% O 2 , 5.25% CO 2 , and 94.75% N 2 . Cells were cultured under these conditions for 6 and 18 h, or incubated with 100 mM of CoCl 2 in normoxic conditions for 6 and 18 h. The cells under hypoxia were treated with or without 1 mM of geldanamycin (GA) for the last 2 h of hypoxic incubation.
Preparation of cell lysates and conditioned medium
Cell pellets were harvested by gently scraping the cells and lysed in a lysis buffer (10 mM Tris, 150 mM NaCl and 1% Nonidet P-40) containing 10% protease inhibitor cocktail (Roche Diagnostic GmbH) on ice for 1 h with two to three times vortexing. The cell lysates were centrifuged, and supernatants were collected. Nuclear protein was extracted using NE-PER Nuclear and Cytoplasmic Extraction Reagent kit (Pierce). Cells were washed with PBS, scraped and pelleted as above, then following manufactures protocol, the cytoplasmic and nuclear fractions were separated. Conditioned medium from cells under normoxic or hypoxic conditions with or without GA treatment were collected and centrifuged to remove any cellular debris. The medium was concentrated using ultrafree-4 centrifugal filter units with a nominal molecular weight limit of 10 kDa (Millipore). The medium was centrifuged for 30 min at 3000 r.p.m. at room temperature, and the conditioned medium was collected. The conditioned medium, cell lysates, and nuclear extracts were quantified using Bradford Protein Assay (Bio-Rad).
Immunoblot analysis
The protein extracts (40 mg) from cell lysates, nuclear extracts, and cytoplasmic extracts were separated on a 10% SDS-PAGE. For concentrated medium, 10 mg of medium was diluted 30-fold in milli-Q water before the loading on the gel. Proteins were separated by electrophoresis and transferred onto a nitrocellulose membrane (Amersham Pharmacia Biotech). The membranes were blocked with 10% skim milk in TBST (10 mM Tris Base, 15 mM NaCl, 0.1% Tween, pH ¼ 8.0) for 1 h at room temperature and incubated overnight at 41C with various primary antibodies in 5% dry skim milk in TBST. Whole lysates and nuclear extracted lysates were probed with either mouse anti-HIF-1a monoclonal antibody diluted 1:2000 (Transduction Laboratories), or with a rabbit polyclonal anti-VEGF antibody (Santa Cruz) diluted 1:1000. Concentrated conditioned medium were probed with a rabbit monoclonal anti-MMP-9 antibody diluted Inhibition of HIF-1a by geldanamycin O Alqawi et al 1:5000 (Triple Point Biologics). After the primary antibody incubation, the membranes were washed three times in TBST buffer and incubated with secondary antibodies (horseradish linked anti-rabbit IgG or goat anti-mouse IgG) diluted 1:5000 in 5% dry skim milk in TBST at room temperature for 1 h. Antibody-antigen complexes were visualized after incubation with 2 ml of ECL Plus detection system (Amersham Pharmacia Biotech) for 5 min at room temperature followed by the exposure to X-OMAT film (Kodak).
Isolation of RNA and RT-PCR
Total RNA was isolated from DU-145 cells using Qiagen RNeasy kit (Qiagen). HIF-1a cDNA was synthesized by using one step RT-PCR (Invitrogen). The primers were 5 0 -ACCGATTCGCCATGGA-3 0 (sense) and 5 0 -GCTCAGT TAACTTGATCCAAAG-3 0 (antisense). The cDNA synthesis and predenaturation conditions were 501C for 30 min followed by 941C for 2 min. The PCR was performed for 30 s at 941C, 30 s at 551C, and 2 min at 681C with total of 40 cycles. The final extension condition was 721C for 5 min. The PCR products were resolved in agarose gel and extracted using QIAquick Gel Extraction Kit (Qiagen). The HIF-1a and b-Actin cDNA probes were labeled with [a 32 P] dATP or dCTP (Perkin Elmer) using the Decalabel DNA labeling kit (MBI Fermentas).
Northern blot analysis
Total RNA (10 mg) from each previously prepared sample mixed with loading dye were run on a 1.5% agarose formaldehyde gel and transferred overnight onto a positively charged nylon membrane (Roche Diagnostics GmbH). After UV cross-linking, membranes were incubated at 651C for 1 h in prehybridization solution (0.5 M Na 2 HPO4, 1% BSA, 1 mM EDTA and 7% SDS). The membranes then were hybridized overnight at 551C with the radiolabeled probes with hybridization solution. The hybridized membranes were washed twice at room temperature in 40 mM Na 2 HPO4, 0.1% BSA, 1 mM EDTA, 1% SDS followed by an additional five washes at room temperature in 40 mM Na 2 HPO 4 , 1 mM EDTA, 1% SDS and a final wash in 100 mM Na 2 HPO 4 at 651C for 20 min. The washed membranes were developed overnight using a phosphor imager (Molecular Dynamics). The membranes were probed with human HIF-1a cDNA and human b-Actin cDNA probe. The intensity of each band on the northern blots was quantified using Image quant software.
ELISA for VEGF
Cell supernatants were collected and centrifuged to remove any cellular debris. VEGF levels were determined by using Quantikine Immunoassay (R&D Systems) according to the manufacturer's instructions. The assay consists of monoclonal VEGF antibody that has been precoated onto a micro plate. VEGF standards and diluted samples were added to the wells in the micro plate and any VEGF was bound to the immobilized antibody. The micro plates were washed, and the enzyme-linked polyclonal VEGF antibody was added to the wells. After washing the micro plates, a substrate solution was added to the wells and color developed in proportion to the amount of VEGF bound in the first step. The color development was stopped, and the intensity of the color was measured by micro plate reader EL340 (Bio-Teck Instrument). The optical density readings produced by the recombinant human VEGF 165 standard were used to produce a standard curve and to determine the concentration of VEGF secreted protein in the conditioned medium samples.
VEGF mRNA quantification
The VEGF mRNA levels were determined using the Quantikine mRNA quantification kit (R&D Systems) according to the manufacturer's instructions. The samples were hybridized with a gene-specific biotin-labeled capture olignucleotide probes and digoxigenin-labeled detection probes in a micro plate. The resultant hybridization was transferred to a streptavidin-coated micro plate where the RNA/probe hybrid was bound. The micro plates were washed and an antidigoxigenin alkaline phosphatase conjugate was added. After washing, a substrate solution followed by an amplifier solution was added. The color development was stopped and the intensity of the color was measured as previously described. VEGF mRNA concentrations for all experimental conditions from three separate experiments averaged and their mean plotted on bar graph with corresponding s.e.
Luciferase reporter assay
DU-145 cells were transiently transfected with luciferase reporter gene construct (5HRE/hCMVmp-luc) using Lipofectamine2000 reagent (Life Technologies Inc.,). After transfection cells were kept in normoxic or hypoxic conditions for 24 h in the presence or absence of 2 mM of GA. After 48 h from the transfection, cells were washed with PBS and lysed. The supernatant was assayed using luciferase assay kit (Stratagene).
Matrigel invasion assay
The cells after the treatment in normoxic or hypoxic conditions were incubated with medium without serum. The conditioned medium was collected and centrifuged. The cells were resuspended in serum-free medium. In all, 20 000 live cells were seeded in an invasion chamber coated with a basement membrane matrix (Becton Dickinson Labware). The lower chamber was filled with medium, which acted as a chemoattractant for the cells in the top matrigel membrane-coated chamber. The matrigel was incubated for 24 h in either the normoxic or hypoxic incubators. The membranes were removed, fixed, stained with hematoxilin, and mounted on slides. The number of cells that had migrated through the membrane were counted in five separate fields for each membrane and averaged. For the matrigel membranes placed in the normoxic incubator, the four chemoattractants were the serum free medium, the serum-free medium plus VEGF (10 ng/ml), the basal-conditioned medium (BCM), and the BCM plus VEGF neutralizing antibody (200 ng/ml)(R&D Systems). For the membranes placed in the hypoxic incubator, the three chemoattractants were the hypoxic-conditioned medium, the hypoxic-conditioned medium plus a VEGF neutralizing 
Detection of metalloproteinase
Gelatin zymogram gels were used to detect MMP-2 and MMP-9. Cells were grown under basal, hypoxic (6 and 18 h) and GA-treated hypoxic (6 and 18 h) conditions. After the cells had adhered to the plate, the normal medium was removed and serum-free medium was added for the duration of the 48-h incubation time. Then the medium was collected and spun down to remove any cellular debris. The loading buffer of the zymogram gel (0.2 M Tris-HCl, 10% SDS, 4% sucrose and 0.1% bromophenol blue) was mixed with the medium before loading onto an 8% SDS-PAGE incorporated with 0.3% gelatin.
The gel was washed in 2.5% Triton X-100 for 30 min. The gel was then incubated with a solution (50 mM Tris-HCl, 5 mM CaCl 2 ) overnight at 371C with continuous shaking. Following this, the gel was stained with 0.05% comassie blue solution for 10 min and destined with a destaining solution (40% methanol, 10% acetic acid, 50% water) until the achromatic bands appeared on the blue background. The density of the bands was quantified by the Adobe Photoshop s (Version 5.1, Adobe Systems).
Results
Hypoxia induces stabilization of HIF-1a in prostate cancer cells
To study the hypoxic response in different prostate cell lines, CL-1, LNCaP, DU-145 and PC-3 cells were exposed to either hypoxia (1% O 2 , 6 h or 18 h) or normoxia (21% O2). Figure 1a shows the different amounts of increase in HIF-1a level in all four cell lines upon exposure to hypoxia 6 and 18 h. LNCaP and CL-1 cells expressed no HIF-1a under normoxia. However, PC-3 cells expressed HIF-1a under normoxia while DU-145 cells slightly expressed HIF-1a under normoxia. All four cell lines had elevated HIF-1a protein induction at 6 h of hypoxia incubation, with decreased HIF-1a levels at the longer 18 h incubation. The increase was significant in DU-145 and PC-3 cell lines for the early (6 h) incubation and in DU-145 and LNCaP cell lines for the longer (18 h) incubation. These results indicated that DU-145 cell line had the most pronounced response to hypoxia at both the 6 and 18-h hypoxia time points. The level of HIF-1a protein induction from the cell lysates of DU-145 was higher at the early 6 h than 18 h hypoxia incubation (Figure 1b ). In addition, we looked at HIF-1a mRNA during normoxia and hypoxia. Figure 1c is a representative northern analysis of HIF-1a mRNA levels. Hypoxia did not alter HIF-1a mRNA levels at either 6 h or 18 h incubation under hypoxia or normoxia, instead it increased HIF-1a stability by increasing its protein levels.
GA inhibits hypoxia-mediated HIF-1a protein stabilization
The synthesis of HIF-1a is associated with the chaperone protein Hsp90. 21 GA inhibits Hsp90 and that reduces HIF-1a protein expression and its transcription activity in prostate cancer cells. Cells were incubated under basal (B) conditions, early (6 h) hypoxic conditions, longer (18 h) hypoxic conditions, early hypoxic conditions with the addition 1 mM of GA for the last 2 h (6GA) or longer hypoxic conditions with the addition of 1 mM of GA for the last 2 h (18 h). HIF-1a protein, nuclear translocation and mRNA were measured. Figure 2a showed the decrease in HIF-1a protein levels upon incubation with 1 mM of GA, and it is more significant in DU-145 cells compared to the other cell lines. We examined the effect of GA incubation time on HIF-1a inhibition. DU-145 cells were incubated in hypoxic conditions for 6 h and treated with 1 mM of GA for the last 2 or 4 h or the entire 6 h (Figure 2b ). The levels of HIF-1a were most dramatically decreased when GA was added for the last 2 h of hypoxic incubation. The HIF-1a levels of cells incubated with GA for 4 and 6 h were much closer to the HIF-1a levels of cells in hypoxia for 6 h with no GA. Based on these data, we chose to add GA for 2 h incubation time in all subsequent experiments. DU-145 cells are used in most of our experiments to measure the levels of HIF-1a under basal or hypoxic conditions (6 and 18 h) with or without Inhibition of HIF-1a by geldanamycin O Alqawi et al 1 mM of GA, and with the addition of DMSO as a control. The Western blots of total cell lysates from DU-145 cells (Figure 2c and d) showed an increase in HIF-1a protein levels, however, the increase was more significant at 6-h time point (Po0.05). The addition of GA caused a decrease in HIF-1a protein levels and more considerable in 6-h hypoxia. The addition of DMSO to the cells did not alter HIF-1a protein level. Similar results obtained for the effect of GA on HIF-1a levels from the nuclear extracts of DU-145 cells under normoxic or hypoxic conditions (Figure 2e and f) . The levels of HIF-1a mRNA were also examined after hypoxic cells were treated with GA as previously described. The northern analysis did not show any difference of HIF-1a mRNA levels in the cells treated or nontreated with GA (data not shown). These data indicate that GA decreases HIF-1a protein level but not HIF-1a mRNA level.
GA inhibits VEGF protein secretion and mRNA upregulation
To examine the transcriptional activity of HIF-1a, the induction of VEGF was evaluated. All the four cell lines (Du-145, CL-1, LNCaP, and PC-3) were incubated in either hypoxia (1% O 2 ) for 6 or 18 h or in normoxia (21%O 2 ). The whole cell lysates were tested by Western blot for VEGF expression. Figure 3a and b show no significant induction of VEGF protein in all cell lines after hypoxia or normoxia. The inhibition of HIF-1a transcriptional activity by GA could consequently affect the target genes as VEGF. To examine that, DU-145 cell line was incubated under normoxia or hypoxia (6 and 18 h) with or without 1 mM of GA. Since all VEGF isoforms are secreted as covalently linked homo-dimers, VEGF secretion was measured in conditioned medium. The secretion of VEGF protein was significantly decreased after the treatment of hypoxic cells with 1 mM Inhibition of HIF-1a by geldanamycin O Alqawi et al of GA (Figure 3c ). This decrease was seen in GA-treated cells incubated for either 6 or 18 h in hypoxia. Furthermore, the effect of GA on VEGF expression was evaluated at the mRNA levels. After hypoxia exposure in the presence or absence of 1 mM of GA the mRNA levels of VEGF were measured as described in Materials and methods. Figure 3d shows a decrease in mRNA levels of VEGF after the treatment with GA under the hypoxic conditions. This decrease was significant for GA treated 6 and 18 h hypoxic cells. Hence, GA decreases the secretion of VEGF protein and mRNA levels in DU-145 cells under hypoxic conditions.
HIF-1 transcriptional activity is abolished by GA
To determine the effect of GA on the transcriptional activity of HIF-1a, we transiently transfected DU-145 cells with luciferase reporter gene construct (5HRE/ hCMVmp-luc) containing five tandem copies of the hypoxia response element derived from the human VEGF promoter. As shown in Figure 4 , luciferase activity was significantly increased (12-fold) in response to hypoxia when cells were transfected with luciferase reporter gene, whereas no induction was seen with nontransfected cells (data not shown). However, the luciferase activity induced by hypoxia was reversed by GA indicating the inhibition of HIF-1a transcriptional activity.
Hypoxia induces matrigel invasion activity in DU-145 cells
Hypoxia has been found to be associated with increased risk of tumor invasion. 24 However, the underlying mechanism is largely unknown. We hypothesized that HIF-1a induction and HIF-1a -mediated VEGF induction under hypoxia may play important roles in prostate cancer cell invasion. To test that, DU-145 cells were incubated under basal conditions, early hypoxic conditions (6 h) or GA treated early hypoxic conditions. The cells were harvested and conditioned medium was collected. The basal cells were plated on matrigel membranes which had either serum-free medium, serum-free medium plus 10 ng/ml of recombinant VEGF protein, conditioned medium from basal cells or BCM plus 200 ng/ml of VEGF neutralizing antibody as chemoattractants. The hypoxic cells were treated on matrigel membrane, which had either conditioned medium from early hypoxic cells, hypoxic conditioned medium plus 200 ng/ml of VEGF neutralizing medium or GA treated hypoxic-conditioned medium. Figure 5a shows that the addition of recombinanat VEGF 165 to serum-free medium led to a significant increase in cell invasion (Po0.05) in comparison to using serum-free medium as a chemoattractant. The BCM led to a significant increase in cell invasion versus serum-free medium alone and serum-free medium plus VEGF 165 . The number of the cells that invaded through the matrigel membrane increased from 15.0071.44 per field using serum free medium to 180.47750.44 per field when using BCM with serum. Similarly, neutralizing VEGF antibody added to wells with BCM as their chemoattractant led to a significant decrease in cell invasion (Po0.05). The number of cells that invaded through decreased from 180.47750.44 per field with BCM to 54.00713.17 per field with the addition of neutralizing antibody. Thus, VEGF plays an important role in cell invasion under the normoxic conditions. Using conditioned medium from cells under hypoxic conditions as a chemoattractant led to a significant increase in cell invasion versus using serum-free medium alone (Po0.05) (Figure 5b 
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Surprisingly, neutralizing VEGF antibody added to wells with hypoxic conditioned medium, did not lead to a significant decrease in cell invasion. The number of cells that invaded through the matrigel when using hypoxic conditioned medium (HCM) was 73.2078.49 per field, while that number was 82.0773.24 per field when the neutralizing antibody was added. This result indicates that adding VEGF neutralizing antibody does not play an important role in the cell invasion during hypoxia. However, using conditioned medium from GA treated hypoxic cells 25 led to a significant decrease in cell invasion in comparison to the wells in which HCM was used (19.6072.60, and 73.2078.49 cells per field, respectively). These data suggest that a decrease in HIF1a leads to a decrease in cell invasion. This decrease is not due to the effect of HIF-1a on VEGF but rather on some other HIF-1a mediated protein(s), which can be decreased by decreasing HIF-1a transcriptional activity by GA.
Hypoxia does not change MMP-2 and MMP-9 levels in DU-145 cells
Since our matrigel data showed an increased invasion of DU-145 cells upon hypoxic incubation, we investigated if hypoxia leads to an increase in the levels of two MMP proteins: MMP2 and MMP-9, which degrade denatured collagens and intact collagen IV, major components of basal lamina. The zymogram gel in Figure 6a and b showed that there was no change in MMP-2 or MMP-9 levels in concentrated conditioned medium of DU-145 cells treated with either hypoxia alone or hypoxia and GA. There was no significant difference between the MMP-2 and MMP-9 levels at 6 and 18 h hypoxic cells and geldanamaycin-treated hypoxic cells. Figure 6c showed the Western blot of MMP-9 protein in unconcentrated conditioned medium of cells under basal conditions, hypoxic conditions (6 and 18 h) and GA-treated hypoxic DU-145 cells. There was no significant increase in secreted MMP-9 protein under hypoxia (6 and 18 h), and the addition of GA did not lead to a significant decrease in MMP-9 secretion. The Western gel was stained with comassie blue dye as a loading control (data not shown). These data indicate that hypoxia or GA treatment does not affect MMP-2 and MMP-9 protein levels. This suggests that the increased invasion observed under hypoxic conditions and decreased invasion observed upon the addition of GA, are caused by other factors but not by MMP-2 or MMP-9 proteins.
Discussion
Hypoxia exerts a selective pressure on tumor cells that become more aggressive and ultimately metastatic. 24 HIF-1a is a transcription factor that is highly upregulated by hypoxia and it regulates more than 60 genes, which are associated with tumor progression. 1 In this work, we examined the effects of hypoxia and the pharmacological inhibition of HIF-1a by GA on HIF-1a protein and its target gene, VEGF in prostate cancer cells. In addition, we studied the effects of hypoxia and VEGF on the invasive ability of those cells. Incubating the four prostate cancer cell lines (CL-1, LNCaP, DU-145 and PC-3) under hypoxia (1% O 2 ) resulted in an induction of HIF-1a protein. DU-145 and PC-3 cell lines expressed higher amounts of HIF-1a protein under hypoxic conditions than the LNCaP and CL-1 cell lines. However, DU-145 and PC-3 cell lines express small amounts of HIF-1a protein in normoxic conditions whereas no change was observed in CL-1 and LNCaP cells. Other studies have also shown that PC-3 cells do express HIF-1a protein in normoxia and it has been shown that the HIF-1a gene-encoding region is highly amplified in these cells. 26 In addition, PC-3 cells have an inactive PTEN gene, which inhibits phosphotidyl inositol3 kinase (PI3K)/protein kinase B (Akt)/FRAP pathway. 27, 28 Hence, in PC-3 cells the PI3K/Akt/FRAP pathway is active accounting for its basal levels of HIF-1a protein.
The hypoxic incubation of HIF-1a in all four cell lines was more pronounced at the 6 h hypoxic time point than at 18 h treatment. Other studies also report decreased HIF-1a induction at longer hypoxic incubation times. 29 They state that PI3K/Akt/FRAP signaling pathway is needed for early HIF-1a protein stabilization in hypoxia by acting to inhibit glycogen synthase kinase3 beta (GSK3b). GSK3b has a potential consensus site in the oxygen-dependent degradation domain (ODD) of HIF-1a. Therefore by inhibiting the activation of GSK3b, HIF-1a protein is stabilized. However, during longer hypoxic incubation (e.g. 16 h) Akt is inactivated and GSK3b is activated leading to a decrease in HIF-1a protein. It is not known whether GSK3b regulates HIF-1a protein degradation or synthesis in hypoxia. Zhong et al. 30 found that HIF-1a was highly upregulated in prostate cancer lesions 
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O Alqawi et al compared with high-grade prostatic intraepithelial neoplasia. This suggests that the upregulation of HIF-1a is an early molecular event in prostate carcinogenesis. GA is a known inhibitor of HIF-1a via its effect on Hsp90 chaperone protein. Adding GA to 6 h hypoxic treated prostate cells resulted in a decrease in HIF-1a protein levels in all the four cell lines. Isaacs et al. 20 showed that the addition of GA promotes the degradation of HIF-1a under hypoxia rather than preventing HIF-1a upregulation. Our results show that neither hypoxia nor GA have any effect on HIF-1a mRNA levels. This indicates that hypoxia does not increase HIF-1a protein production but stabilizes HIF-1a protein. HIF-1a is constantly being produced; however, as soon as it is produced it is ubiquitnated by an E3 ubiquitin ligase complex and targeted for proteasomal degradation. Hypoxia prevents the ubiquitination and proteasomal degradation of HIF-1a. GA works by inhibiting the association of HIF-1a protein with Hsp90 chaperone protein, which is required for its stabilization. It has been shown that GA mediated a decrease in HIF-1a can be inhibited by proteasomal inhibitors. 22 The transcriptional activity of HIF-1a is inhibited by GA was demonstrated by luciferase activity assay. DU-145 cells transiently transfected with luciferase gene under hypoxia have increased its activity compared with the transfected cells in normoxia. However, GA inhibits this increase of luciferase activity. Since VEGF is transcriptionally upregulated by HIF-1a, secreted levels of VEGF protein were measured. Our results showed an increase of the secreted VEGF protein levels under hypoxia as it was shown in other studies. 31 To further verify this result, we examined the levels of VEGF mRNA under normoxia or hypoxia. VEGF mRNA was in fact upregulated in hypoxia but not in normoxia. Hypoxic cells treated with GA showed both a decrease in secreted VEGF protein and in VEGF mRNA levels. Blagosklonny et al. 32 showed that the treatment of Hep3 cells with radicicol, another Hsp90 inhibitor, significantly reduced hypoxia-induced DNA binding of the HIF-1a complex which led to a decrease in HIF-1a transcriptional activation of its target genes. In addition, Mabjeesh et al. 22 found that GA inhibited HIF-1a transcriptional activity in hypoxic treated PC-3 cells. These reports are in agreement with our results that GA decreases HIF-1a transcriptional activity of VEGF.
We examined whether HIF-1a and VEGF upregulation in prostate cells led to increased invasion. Our matrigel experiments under normoxic conditions demonstrated that VEGF has the ability to cause an increase in DU-145 cell invasion. Adding recombinant VEGF 165 to the normoxic conditioned medium with serum significantly decreased the invasion. These results indicate that VEGF in addition to playing a paracrine role in cell invasion by stimulating endothelial cells to form new blood vessels, it also plays an autocroine role in invasion by acting as a chemoattractant to tumor cells and causing them to invade through the extracellular matrix. Using ovarian tumor cell lines transfected with VEGF cDNA showed that after transfection there was an increase in VEGF protein expression and an increase in invasion for the tumor cells through matrigel membranes. VEGF has been shown to increase cell migration in T-cell leukemia cell lines. These cell lines also show Flt-1 expression, indicating that these cells secrete VEGF and upregulate their own chemotactic activity through Flt-1 and increase their invasiveness. 33 When hypoxic conditioned medium was used as a chemoattractant on DU-145 cells, there was an increase in invasion in comparison to using serum free medium as a chemoattractant. However, this increased invasion was not due to VEGF since VEGF neutralizing antibody did not reduce invasion. Other factors may be released under hypoxia that may overshadow the effects of VEGF on DU-145 cell invasion. Alternatively, there may be factors that present in the BCM that are not present in the hypoxic-conditioned medium, which interact with VEGF to result in its ability to increase tumor invasion. Plasminogen activator inhibitor-1 (uPAI-1) and urokinase plasminogen activator receptor (uPAR) have been shown to increase the invasion of hypoxic breast carcinoma cells, human melanoma cells, and colon carcinoma cells. 34, 35 Hence, the increased invasion of DU-145 prostate cancer cells in hypoxia maybe due to the effects of HIF-1a on PAI-1 or uPAR. The addition of GA under hypoxic conditions did cause a decrease in prostate cancer cell invasion. Whether this decrease is due to the effect of GA on HIF-1a or some other Hsp90 client protein. Other studies indicate that GA does in fact lead to a decrease in tumor cell invasion by downregulating of TGF-a, MMPs, uPAR, and VEGF. 34, 36 In addition, GA has been shown to cause degradation of mutated or overexpressed signaling proteins implicated in cancer, such as mutant p53, Akt kinase, Raf-1 kinase, some cycline-dependent kinases, and steroid receptors. 21 Solit et al. 37 used 17-allyamino-17-demethoxydGA (17-AAG), a derivative of GA in prostate cancer cell lines. They found that 17-AAG inhibited anchorage-dependent growth of prostate cancer cell lines by retinoblastoma dependent G1 growth arrest and by the downregulation of HER2, HER3 (members of receptor kinases), and androgen receptor (AR). Hence, the GA-dependent decrease in invasion observed in our study may be due to its effects on these proteins in addition to its effects on HIF-1a and its target genes.
VEGF has been shown to increase MMP expression in vascular smooth muscle cells, ovarian carcinomas, endothelial cells, and leukemic cells. 16, [38] [39] [40] Our results indicated that in DU-145 cells MMP-9 and MMP2 levels did not change upon incubation in hypoxia or with the addition of GA to hypoxic-treated cells 18 used breast cancer cells to demonstrate in certain hypoxic cell lines in fact lead to increased MMP-9 but not MMP-2 levels. However, they kept their cells in hypoxia for 24 h. Other studies have demonstrated that VEGF can upregulate MMP-9 via its activation of VEGF receptors in different cell lines. 25, 41 They showed an increase in VEGF protein due to VEGF cDNA transfection resulted in an increase in MMP-2 protein. So the upregulation of MMP-2 and MMP-9 by hypoxia or VEGF may be cell type specific, and VEGF or hypoxia in DU-145 cells may not regulate MMP-2 and MMP-9.
In conclusion, hypoxia causes an increase in HIF-1a protein and its transcriptional activity, which in turn increases VEGF protein in DU-145 cells. Both VEGF and hypoxia correlate with an increase in DU-145 cell invasion. However, both MMP-2 and MMP-9 levels were not increased suggests that the increased invasion in DU-145 cells is occurring through other mechanisms, possibly other MMPs. The pharmacological inhibition of Inhibition of HIF-1a by geldanamycin O Alqawi et al HIF-1a by GA in hypoxic DU-145 cells leads to a decrease in HIF-1a protein, VEGF protein, and invasion. These results suggest that GA; its derivatives or other Hsp90 inhibitors could be used as potential candidates for limiting the invasion and angiogenesis in hypoxic prostate cancer cells.
